A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models.
Lightcap ES, Yu P, Grossman S, Song K, Khattar M, Xega K, He X, Gavin JM, Imaichi H, Garnsey JJ, Koenig E, Zhang H, Lu Z, Shah P, Fu Y, Milhollen MA, Hatton BA, Riceberg J, Shinde V, Li C, Minissale J, Yang X, England D, Klinghoffer RA, Langston S, Galvin K, Shapiro G, Pulukuri SM, Fuchs SY, Huszar D..
. Goel RR, et al. bioRxiv. 2021 Aug 23:2021.08.23.457229. doi: 10.1101/2021.08.23.457229. Preprint. bioRxiv. 2021. PMID: 34462751. Free PMC article.
.
Gharagozloo M, et al. Acta Neuropathol. 2021 Sep 6. doi: 10.1007/s00401-021-02366-4. Online ahead of print. Acta Neuropathol. 2021. PMID: 34487221. Zhang Y, et al. JAMA Cardiol. 2021 Sep 22. doi: 10.1001/jamacardio.2021.3508. Online ahead of print. JAMA Cardiol. 2021. PMID: 34550307
![top](data:image/svg+xml,%3Csvg%20xmlns="http://www.w3.org/2000/svg"%20width="16"%20height="16"%3E%3Crect%20fill-opacity="0"/%3E%3C/svg%3E "top")